Evidence map›Paper›PMID 41350250›Full record

ArticleNature communications2025

Structural mechanism of mRNA decoding by mammalian GTPase GTPBP1.

Denis Susorov, Anna Miścicka, Dmitrij Golovenko, Anna B Loveland, Alexandra Zinoviev, Tatyana V Pestova, Andrei A Korostelev

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. RNAViruses · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Denis SusorovRNA Therapeutics Institute, UMass Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0009-0009-5925-9459
Anna MiścickaDepartment of Cell Biology, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Dmitrij GolovenkoRNA Therapeutics Institute, UMass Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0003-0120-1405
Anna B LovelandRNA Therapeutics Institute, UMass Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0001-9172-7747
Alexandra ZinovievDepartment of Cell Biology, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Tatyana V PestovaDepartment of Cell Biology, SUNY Downstate Health Sciences University, Brooklyn, NY, USA. tatyana.pestova@downstate.edu.ORCID http://orcid.org/0000-0003-3543-256X
Andrei A KorostelevRNA Therapeutics Institute, UMass Chan Medical School, Worcester, MA, USA. andrei.korostelev@umassmed.edu.ORCID http://orcid.org/0000-0003-1588-717X

Funding

Translational Control: Discovery and MechanismsR35GM127094 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Andrei Korostelev · 2018 to 2026
$5.5M
Mechanisms of eukaryotic translation and ribosome-associated mRNA surveillance and protein quality controlR35GM122602 · NIGMS · SUNY DOWNSTATE MEDICAL CENTER · PI TATYANA V PESTOVA · 2017 to 2026
$4.8M
NIGMS NIH HHS R35 GM122602NIGMS NIH HHS R35 GM127094U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35GM127094
6 · The paper itself

Abstract

GTP-binding protein 1 (GTPBP1) is a widespread translational GTPase closely related to elongation factor eEF1A. The loss of GTPBP1 leads to neurodevelopmental and neurodegenerative disorders in animals. Although linked to translation and quality control mechanisms, GTPBP1 molecular functions remain largely obscure. Similarly to eEF1A, GTPBP1 delivers aminoacyl-tRNA to the ribosome, but the ensuing GTPBP1-mediated elongation is slow. Here, using cryo-EM of mammalian 80S ribosomal complexes bound to GTPBP1 and aa-tRNA with GTP or the non-hydrolysable analog GDPCP, we show that the distinct GTPBP1 architecture and interactions with tRNA underlie slow GTPBP1 dissociation after GTP hydrolysis, resulting in delayed tRNA accommodation. Slow dissociation correlates with an extended proofreading stage and higher accuracy of GTPBP1-mediated decoding, potentially allowing GTPBP1 to elicit its putative quality control functions. GTPBP1 visualization provides the foundation for mapping and elucidating GTPBP1 mutations associated with human diseases.

Indexed as

GTP-Binding ProteinsMonomeric GTP-Binding ProteinsRNA, MessengerAnimalsCryoelectron MicroscopyGuanosine TriphosphateHumansHydrolysisPeptide Elongation Factor 1Protein BindingProtein BiosynthesisRibosomesRNA, TransferRNA, Transfer, Amino AcylGBP1 protein, humanGTP-Binding ProteinsGuanosine TriphosphateMonomeric GTP-Binding ProteinsPeptide Elongation Factor 1RNA, MessengerRNA, TransferRNA, Transfer, Amino Acyl

Identifiers

PMID41350250
PMCPMC12775451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.